carprofen

carprofen. It is a nonsteroidal anti-inflammatory drug of the arylpropionic acid class, primarily used in veterinary medicine for the management of pain and inflammation. Marketed under brand names such as Rimadyl and Novox, it is commonly prescribed for osteoarthritis in dogs and for postoperative analgesia following procedures like orthopedic surgery. Its development and approval were spearheaded by companies including Pfizer and its animal health division, Zoetis.

Medical uses

The primary medical use is the control of pain and inflammation associated with canine osteoarthritis and soft tissue surgery. It is frequently administered perioperatively to provide analgesia following procedures such as cruciate ligament repair and hip dysplasia surgery. Veterinary professionals also utilize it for managing acute pain in other species under specific regulatory approvals, as determined by organizations like the Food and Drug Administration Center for Veterinary Medicine and the European Medicines Agency. Its prescription is typically contraindicated in animals with known hypersensitivity to NSAIDs or those with significant renal impairment.

Adverse effects

Reported adverse effects are generally mild but can include gastrointestinal ulceration, vomiting, and diarrhea. More serious but rare complications involve hepatotoxicity, particularly in certain breeds like the Labrador Retriever, and idiosyncratic drug reactions affecting the liver. Concurrent administration with other nephrotoxic agents, such as aminoglycosides or corticosteroids, may potentiate acute kidney injury. Monitoring protocols recommended by the American College of Veterinary Internal Medicine often include periodic assessment of serum biochemistry profiles to detect hepatic or renal dysfunction early.

Pharmacology

It acts as a non-selective inhibitor of the cyclooxygenase enzymes, COX-1 and COX-2, thereby reducing the synthesis of prostaglandins and thromboxanes involved in inflammation and pain signaling. The drug is well-absorbed orally and undergoes extensive hepatic metabolism primarily via glucuronidation, with excretion mainly through the bile and feces. Its pharmacokinetic profile demonstrates high bioavailability in dogs, and its effects are mediated through modulation of the arachidonic acid cascade, similar to other agents in its class like ketoprofen and naproxen.

Chemistry

Chemically, it is a tricyclic compound belonging to the carbazole family, specifically a 2-arylpropionic acid derivative. The molecular structure features a chlorine substituent at the 6-position of the carbazole ring system, which influences its lipophilicity and receptor binding affinity. It is a white to off-white crystalline powder that is practically insoluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. The compound's synthesis was first described in patents held by Hoffmann-La Roche, and its stereochemistry involves a chiral center at the alpha-carbon of the propionic acid side chain.

Society and culture

The drug has been a significant product in the veterinary pharmaceutical market since its introduction by Pfizer Animal Health. High-profile legal cases, such as those discussed in reports by the United States Department of Justice, have involved issues of off-label use and promotional practices. Its availability is strictly by veterinary prescription in most jurisdictions, governed by regulations from bodies like the Veterinary Medicines Directorate in the United Kingdom. The medication is also a topic of discussion within organizations like the American Veterinary Medical Association concerning responsible analgesic stewardship and animal welfare standards.

Category:Nonsteroidal anti-inflammatory drugs Category:Veterinary drugs Category:Carbazoles